Ben Tre Pharmaceutical JSC (HOSE:DBT)

Market Cap	252.53B
Revenue (ttm)	863.36B
Net Income (ttm)	17.52B
Shares Out	20.53M
EPS (ttm)	852.94
PE Ratio	14.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,453
Average Volume	10,505
Open	12,300
Previous Close	12,100
Day's Range	12,200 - 12,300
52-Week Range	10,600 - 13,550
Beta	0.53
RSI	50.36
Earnings Date	Oct 30, 2025

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 774
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2024, HOSE:DBT's revenue was 868.41 billion, an increase of 7.00% compared to the previous year's 811.62 billion. Earnings were 13.49 billion, an increase of 4.02%.